• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[2014 European Society of Cardiology guidelines on hypertrophic cardiomyopathy].

作者信息

Özdemir Murat

机构信息

Department of Cardiology, Gazi University Faculty of Medicine, Ankara, Turkey.

出版信息

Turk Kardiyol Dern Ars. 2014 Dec;42(8):693-7. doi: 10.5543/tkda.2014.34984.

DOI:10.5543/tkda.2014.34984
PMID:25620328
Abstract
摘要

相似文献

1
[2014 European Society of Cardiology guidelines on hypertrophic cardiomyopathy].[2014年欧洲心脏病学会肥厚型心肌病指南]
Turk Kardiyol Dern Ars. 2014 Dec;42(8):693-7. doi: 10.5543/tkda.2014.34984.
2
Bernard J. Gersh, Mayo Clinic, Rochester, MN, USA, provides a transatlantic perspective on the 2014 European Society of Cardiology Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy.美国明尼苏达州罗切斯特市梅奥诊所的伯纳德·J·格什对2014年欧洲心脏病学会肥厚型心肌病诊断和管理指南提供了跨大西洋视角的解读。
Eur Heart J. 2015 Jan 1;36(1):7-8.
3
[2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].[2014年欧洲心脏病学会肥厚型心肌病诊断和管理指南]
Kardiol Pol. 2014;72(11):1054-126. doi: 10.5603/KP.2014.0212.
4
Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.验证 2014 年欧洲心脏病学会指南风险预测模型在肥厚型心肌病患者中的一级预防心源性猝死的应用。
Circ Arrhythm Electrophysiol. 2015 Aug;8(4):829-35. doi: 10.1161/CIRCEP.114.002553. Epub 2015 Apr 28.
5
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM).2014 年欧洲心脏病学会肥厚型心肌病猝死预防指南的国际外部验证研究（EVIDENCE-HCM）。
Circulation. 2018 Mar 6;137(10):1015-1023. doi: 10.1161/CIRCULATIONAHA.117.030437. Epub 2017 Nov 30.
6
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断与治疗指南：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
J Thorac Cardiovasc Surg. 2011 Dec;142(6):e153-203. doi: 10.1016/j.jtcvs.2011.10.020.
7
A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.一项对 2003 年美国心脏病学会/欧洲心脏病学会和 2011 年美国心脏病学会基金会/美国心脏协会用于肥厚型心肌病患者心源性猝死风险分层和治疗算法的验证研究。
Heart. 2013 Apr;99(8):534-41. doi: 10.1136/heartjnl-2012-303271. Epub 2013 Jan 22.
8
Validation of the 2014 European Society of Cardiology Sudden Cardiac Death Risk Prediction Model Among Various Phenotypes in Japanese Patients With Hypertrophic Cardiomyopathy.验证 2014 年欧洲心脏病学会在日本肥厚型心肌病患者各种表型中的心脏性猝死风险预测模型。
Am J Cardiol. 2018 Dec 1;122(11):1939-1946. doi: 10.1016/j.amjcard.2018.08.042. Epub 2018 Sep 8.
9
Predicting therapies in Japanese hypertrophic cardiomyopathy patients with an implantable cardioverter-defibrillator using the 2014 European Society of Cardiology guidelines.利用 2014 年欧洲心脏病学会指南预测植入式心脏复律除颤器的日本肥厚型心肌病患者的治疗方法。
Heart Vessels. 2021 Jan;36(1):99-104. doi: 10.1007/s00380-020-01668-z. Epub 2020 Jul 15.
10
A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy.欧洲心脏病学会儿童肥厚型心肌病心脏性猝死风险分层指南验证研究。
Europace. 2019 Oct 1;21(10):1559-1565. doi: 10.1093/europace/euz118.

引用本文的文献

1
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine.心血管医学中药物或器械随机试验的特点和影响。
Am J Cardiovasc Drugs. 2024 Sep;24(5):651-661. doi: 10.1007/s40256-024-00670-4. Epub 2024 Aug 1.
2
Public Health Dimensions of CVD Prevention and Control - Global Perspectives and Current Situation in the Federation of BiH.心血管疾病预防与控制的公共卫生层面——全球视角与波黑联邦的现状
Mater Sociomed. 2023;35(2):88-93. doi: 10.5455/msm.2023.35.88-93.
3
Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland.
因新型冠状病毒肺炎住院患者心房颤动的患病率及临床意义：来自波兰一项登记研究的数据
Front Cardiovasc Med. 2023 Mar 13;10:1133373. doi: 10.3389/fcvm.2023.1133373. eCollection 2023.
4
Conflicts of interest in electrophysiology and devices presentations.电生理学和设备演示中的利益冲突。
Europace. 2023 Feb 16;25(2):660-666. doi: 10.1093/europace/euac205.
5
The World Heart Observatory: Harnessing the Power of Data for Cardiovascular Health.世界心脏观测站：利用数据力量促进心血管健康。
Glob Heart. 2022 Jun 6;17(1):36. doi: 10.5334/gh.1126. eCollection 2022.
6
Clinical efficacy of ceftazidime combined with levofloxacin on heart failure complicated with pulmonary infection and its influence on cardiopulmonary function.头孢他啶联合左氧氟沙星治疗心力衰竭合并肺部感染的临床疗效及其对心肺功能的影响
Am J Transl Res. 2021 Apr 15;13(4):2590-2598. eCollection 2021.
7
Considerations for Management of Acute Coronary Syndromes During the SARS-CoV-2 (COVID-19) Pandemic.急性冠状动脉综合征在 SARS-CoV-2（COVID-19）大流行期间的处理注意事项。
Am J Cardiol. 2020 Sep 15;131:115-119. doi: 10.1016/j.amjcard.2020.06.039. Epub 2020 Jun 30.
8
Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort Study.肾素-血管紧张素-醛固酮系统抑制剂与韩国 2019 冠状病毒病（COVID-19）相关结局的关联：一项全国基于人群的队列研究。
Clin Infect Dis. 2020 Nov 19;71(16):2121-2128. doi: 10.1093/cid/ciaa624.
9
Patients, clinicians and researchers working together to improve cardiovascular health: a qualitative study of barriers and priorities for patient-oriented research.患者、临床医生和研究人员共同努力改善心血管健康：一项关于以患者为导向研究的障碍和优先事项的定性研究
BMJ Open. 2020 Feb 6;10(2):e031187. doi: 10.1136/bmjopen-2019-031187.
10
Usefulness of Modern Activity Trackers for Monitoring Exercise Behavior in Chronic Cardiac Patients: Validation Study.现代活动追踪器在监测慢性心脏病人运动行为中的作用：验证研究。
JMIR Mhealth Uhealth. 2019 Dec 19;7(12):e15045. doi: 10.2196/15045.